We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NOA:NYSENorth American Construction Group Ltd. Analysis

Data as of 2026-04-20 - not real-time

$13.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

North American Construction Group trades around $13.99, well below its DCF-derived fair value of $57.30, implying an upside of roughly 80%. The stock’s valuation metrics reinforce this gap: a trailing P/E of 16.9 is comfortably under the industry average of 21.2, and the forward P/E of 5.9 signals strong earnings acceleration. Technicals are neutral to mildly bullish: price sits just above the 20‑day SMA (~13.95), the RSI is near 46, and the MACD histogram is positive, while volume trends downward, hinting at limited short‑term momentum. The company pays a 2.48% dividend with a modest payout ratio of 42%, but free cash flow is negative and debt‑to‑equity is high at 205%, raising sustainability questions. Recent news adds mixed signals – a Canaccord upgrade provides a catalyst, yet the abrupt resignation of CEO Joe Lambert introduces short‑term leadership uncertainty. Overall, the blend of deep valuation discount, reasonable dividend yield, and sector‑specific risks suggests a buy stance for investors with a medium‑to‑long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • CEO transition creates near‑term uncertainty
  • Neutral technical stance with decreasing volume
  • Canaccord upgrade provides a modest positive catalyst

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Strong forward earnings growth (forward EPS $2.35 vs trailing $0.83)
  • Attractive dividend yield relative to peers

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued price relative to industry multiples
  • Potential for debt reduction as operating cash flow remains positive
  • Diversified geographic exposure across North America and Australia

Key Metrics & Analysis

Financial Health

Profit Margin2.63%
P/E Ratio16.9
ROE8.00%
ROA3.91%
Debt/Equity205.12
P/B Ratio1.2
Op. Cash Flow$264.1M
Free Cash Flow$-35264000
Industry P/E21.2

Technical Analysis

TrendNeutral
RSI46.1
Support$12.92
Resistance$14.90
MA 20$13.95
MA 50$15.02
MA 200$14.63
MACDBullish
VolumeDecreasing
Fear & Greed Index87.63

Valuation

Fair Value$57.30
Target Price$25.40
Upside/Downside81.55%
GradeUndervalued
TypeGrowth
Dividend Yield2.48%

Risk Assessment

Beta1.05
Volatility102.52%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.